Skip to content
OpenCapital
Get started

AbbVie ABBV Botox Cosmetic — Net revenues

Other product segments

Skyrizi
$4.48B+30.9%
Rinvoq
$2.12B+23.3%
All other
$1.03B-18.2%
Botox Therapeutic
$1.01B+16.5%
Vraylar
$905M+18.3%
Venclexta
$770M+15.8%
Humira
$688M-38.6%
Imbruvica
$556M-24.7%
Mavyret
$351M+14.7%
Ubrelvy
$339M+41.3%
Qulipta
$296M+53.4%
Other Aesthetics
$286M-9.2%
Linzess
$283M+91.2%
Juvederm Collection
$232M+0.4%
Vyalev
$201M+219%
Elahere
$198M+10.6%
Other Neuroscience
$125M-19.4%
Epkinly
$83M+62.7%

Similar metrics at other companies

Evolus logo
EOLSProduct revenue, net — Total net revenues
$72.75M+6.9%
Coty logo
COTYConsumer Beauty — Net revenues
$450.7M-4.0%
Ardelyx logo
ARDXProduct sales, net — Total revenues
$93.37M+37.7%
NuSkin Enterprises logo
NUSBeauty — Revenue
$142.03M-16.7%
Castle Biosciences logo
CSTLNon-Dermatologic — NET REVENUES
$42.57M+70.1%
ANI Pharmaceuticals logo
ANIPCortrophin Gel — Net Revenues
$75.12M+42.1%

Other financials

Income statement

See full
Revenue$15.0B+12.4%
Gross profit$10.8B+15.4%
Operating income$4.0B+6.9%
Net income$695.0M-46.0%
EPS (diluted)$0.39-45.8%

Balance sheet

See full
Cash & equivalents$9.4B+81.5%
Total debt$62.4B+1.8%
Total equity-$6.7B-569%
Total assets$136.46B+0.2%

Cash flow

See full
Operating cash flow$3.8B+134%
CapEx$265.0M+12.8%
Free cash flow$3.6B+155%

Valuation

See full
Market cap$465.2B+39.1%
P/E128×+39.1×
P/S7.4×+1.7×

Profitability

See full
Gross margin70.7%0.0pp
Operating margin24.4%—
Net margin5.8%-1.5pp
FCF margin31.8%+5.0pp

Returns & leverage

See full
Return on equity89%+32.7pp
Debt / equity46.6×+38.6×
Current ratio0.8×0.0×

Where this comes from

Reported directly by AbbVie in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbbVie's botox cosmetic — net revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AbbVie's botox cosmetic — net revenues?
AbbVie (ABBV) reported botox cosmetic — net revenues of $668M in Q1 2026.
How has AbbVie's botox cosmetic — net revenues changed year-over-year?
AbbVie's botox cosmetic — net revenues increased by 20.1% year-over-year, from $556M to $668M.
What is the long-term trend for AbbVie's botox cosmetic — net revenues?
Over 4 years (2021 to 2025), AbbVie's botox cosmetic — net revenues has grown at a 3.9% compound annual growth rate (CAGR), from $2.23B to $2.6B.
What does botox cosmetic — net revenues mean?
This metric represents the total gross sales of the Botox Cosmetic product line after accounting for returns, allowances, and rebates. It serves as a key indicator of consumer demand and market penetration within the medical aesthetics industry. Tracking this revenue stream provides insight into the brand's competitive positioning and the sustainability of the company's aesthetic portfolio.